- Gombosev, Adrijana;
- Fouad, Salah E;
- Cui, Eric;
- Cao, Chenghua;
- Terpstra, Leah;
- Avery, Taliser R;
- Kim, Diane;
- Meyers, Hildy;
- Cheung, Michele;
- Huang, Susan S
We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher.